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MaOBJECTIVES The aim of this study is to show a simpliﬁed reversible approach to investigate and conﬁrm vagal
denervation at any time during the ablation procedure without autonomic residual effect.
BACKGROUND Parasympathetic denervation has been increasingly applied in ablation procedures such as in vagal-
related atrial ﬁbrillation and cardioneuroablation. This method proposes an easy way to study the vagal effect and to
conﬁrm its elimination following parasympathetic denervation through vagal stimulation (VS) by an electrophysiological
catheter placed in the internal jugular vein.
METHODS A prospective controlled study including 64 patients without signiﬁcant cardiopathy (48 male [75.0%], age
46.4  16.4 years) who had a well-deﬁned RF ablation indication for symptomatic arrhythmias, comprising a “dener-
vation group” (DG), with indication for ablation with parasympathetic denervation (vagal-related atrial ﬁbrillation or
severe cardioinhibitory syncope) and a “control group” (CG), with ablation indication without parasympathetic dener-
vation (accessory pathway or ventricular arrhythmia). By using a neurostimulator, both groups underwent non simul-
taneous bilateral VS (8 to 12 s, frequency: 30 Hz, pulse width: 50 ms, amplitude: 0.5 to 1 V/kg up to 70 V) through the
internal jugular vein pre- and post-ablation.
RESULTS Signiﬁcant cardioinhibition was achieved pre-ablation in all cases (pause of 11.5  1.9 s in DG vs. 11.4  2.1 s in
CG; p ¼ 0.79). Eight patients (12.5%) presented catheter progression difﬁculty in 1 jugular vein (2 right, 6 left); however,
the contralateral VS was adequate for cardioinhibition. After ablation, the cardioinhibition was reproduced only in CG
(pause of 11.2  2.2 s) as in DG it was entirely eliminated. There was no signiﬁcant difference between pre- and post-
ablation cardioinhibition in CG (p ¼ 0.84). There was no complication (follow-up 8.8  5 months).
CONCLUSIONS The vagal stimulation was feasible, easy, and reliable, and showed no complications. It may be
repeated during the procedure to control the denervation degree without residual effect. It could be a suitable tool for
vagal denervation conﬁrmation or autonomic tests during electrophysiological studies. Ablation without parasympathetic
denervation did not change the vagal response. (J Am Coll Cardiol EP 2015;1:451–60) © 2015 by the American College of
Cardiology Foundation. Published by Elsevier, Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).P arasympathetic denervation has been appliedin several ablation procedures, such as invagal-related atrial ﬁbrillation (VRAF) ablation
(1,2,3) or for treating functional bradyarrhythmias
(cardioneuroablation [CNA]) (4). The success of this
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as the high-frequency endocardial stimulation (5,6)
and atropine response abolition (7). High-frequency
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ABBR EV I A T I ON S
AND ACRONYMS
AF = atrial ﬁbrillation
AV = atrioventricular
CNA = cardioneuroablation
GP = ganglionated cardiac
plexuses, cardiac paraganglia
IVC = inferior vena cava
RF = radiofrequency
SVC = superior vena cava
VRAF = vagal-related atrial
ﬁbrillation (during sleep, at
rest, after meals, and in the
physical exercise recovery)
VS = vagal stimulation
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452during atrial ﬁbrillation (AF), it is more trou-
blesome during sinus rhythm. On the other
hand, atropine infusion results in lasting and
signiﬁcant autonomic changes that may
hamper any complementary ablation in the
same session. The method presented here
proposes an easy way to reproduce a massive
vagal effect and, as the most important corol-
lary, allows for checking its elimination
following the presumed parasympathetic
denervation. This method is carried out
through endovenous vagal stimulation (VS)
in the neck by using any bipolar electrophysi-
ological catheter, even the radiofrequency
(RF) catheter, forwarded up to the jugular fo-
ramen in the internal jugular vein.METHODS
STUDY DESIGN. This prospective controlled study
comprised 2 groups: the “denervation group” (DG)
underwent ablations targeting vagal tone reduction,
and the “control group” (CG) submitted to conven-
tional ablations without aiming vagal tone modiﬁca-
tion. Both were submitted to a similar routine of
catheter RF ablation. VS were identically performed
before and after ablations to compare the results in
both groups. The control group was included to verify
whether the autonomic changes obtained at the end
of the intervention resulted from a real denervation
or if they were a nonspeciﬁc ablation outcome.
PATIENTS. Recruitment of patients began on July 6,
2013, and ended on December 17, 2014. A total of
64 patients without signiﬁcant structural heart dis-
ease (48 male [75.0%], age 46.4  16.4 years) with
symptomatic arrhythmias and a well-deﬁned indica-
tion for RF ablation were included. Written informed
consent was obtained from all patients before the
procedure. They were distributed into the DG, having
indication for ablation with autonomic intervention
(vagal denervation for treating AF clinically related to
vagal tone or severe cardioinhibitory syncope), and
the CG, with ablation indication without autonomic
intervention (accessory pathways or benign ventric-
ular ectopic beats and/or idiopathic ventricular
tachycardia). General features of the patients are
depicted in Table 1. In the DG, there were 47 patients
with severe cardioinhibitory syncope or AF clini-
cally associated with high vagal tone who underwent
vagal denervation (vagal denervation aimed and per-
formed), following methodology previously published
(4,9). The CG included 17 patients who under-
went conventional ablation of accessory pathways,symptomatic benign premature beats, or idiopathic
nonsustained ventricular tachycardia (vagal dener-
vation not aimed and not performed).
Inclusion criteria for the DG were:
1. Absence of signiﬁcant structural cardiopathy;
2. Severe cardioinhibitory syncope or VRAF (AF
clinically related to increased vagal tone: during
sleep, at rest after meals, and in the physical ex-
ercise recovery);
3. Severe cardioinhibition conﬁrmed by head-up tilt
test or Holter monitoring with symptom repro-
duction or AF recording related to high vagal tone;
4. Pacemaker indication at least by 1 clinician as a
consequence of clinical treatment refractoriness in
case of neurocardiogenic syncope;
5. Refractoriness to at least 2 antiarrhythmic drugs in
case of AF;
6. Positive response to atropine test (0.04 mg/kg
intravenous atropine up to a maximal dose of 2 mg,
causing the heart rate to double or to reach >100
beats/min for at least 15 min); and
7. Absence of a metabolic or systemic disease that
could be the syncope or AF origin.
Inclusion criteria for the CG were:
1. Absence of signiﬁcant structural cardiopathy;
2. Frequent symptomatic ventricular ectopic beats
and/or nonsustained monomorphic ventricular
tachycardia with indication for catheter RF abla-
tion, or symptoms or risk related to an accessory
pathway with guideline ablation indication; and
3. Absence of a coronary, inﬂammatory, metabolic, or
systemic disease that could be the arrhythmia
origin.
MATERIALS. Materials included irrigated RF ablation
catheter Biosense Webster (Johnson & Johnson, Dia-
mond Bar, California), Duo-decapolar catheter for
coronary sinus (St. Jude Medical, Minnetonka, Min-
nesota), transseptal puncture system (St. Jude Medi-
cal), Inquiry AFocus II circular decapolar catheter (St.
Jude Medical, Irvine, California), customized neuro-
stimulator (Pachón & Pachón, Sao Paulo, Brazil) and
other support systems including: Velocity electro-
anatomic system (St. Jude Medical, St. Paul, Minne-
sota), Atakr II RF Generator (Medtronic, Minneapolis,
Minnesota), BIS spectral system (Philips, Böblingen,
Germany), Anesthesia (Drager workstation, Lubeck,
Germany) intraesophageal echocardiography (Philips,
Bothell, Washington), intraesophageal multipolar
thermometer (Circa Scientiﬁc, Englewood, Colorado),
and GE OEC 9900 radiological workstation (GE, Salt
Lake City, Utah).
TABLE 1 Baseline Demographic and Clinical Data of Patients
Total
Patients 64
Male/female 48 (75)/16 (25)
Age, yrs 42.5  8.7
Denervation group (ablation with vagal ablation)
n 47
Male/female 37 (78.7)/10 (21.3)
Age, yrs 50.3  15.2
Ablation indication
VRAF 40 (85.1)
Severe cardioinhibitory syncope 7 (14.9)
Control group (ablation without vagal ablation)
n 17
Male/female 11 (64.7)/6 (35.3)
Age, yrs 35.6  15.0
Ablation indication
Benign VEB/idiopathic VT 4 (23.5)
Accessory pathways 13 (76.5)
Follow-up for VS, months 8.8  5.0
Values are n, n (%), or mean  SD.
VEB ¼ ventricular ectopic beat; VRAF ¼ vagal-related atrial ﬁbrillation; VS ¼ vagal stimulation;
VT ¼ ventricular tachycardia.
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453Vagal s t imulator . The vagal stimulator used in this
study presents the following features: DC stimulation
with square wave pulses of 50 ms in duration,
frequency of 30 Hz, and amplitude from 10 to 70 V,
adjusted according to patient features (Figure 1A). An
extremely short pulse duration with current limita-
tions was employed for preventing tissue lesions. In
addition, a timer function allowed the application of
pulse trains with pre-deﬁned timing, usually between
8 and 12 s.
Vagal s t imulat ion . The stimulation was obtained
by an endovascular electrical ﬁeld created in the
internal jugular vein from the distal and the third
pole of the ablation catheter, temporarily used as a
stimulation catheter detached from the RF generator
(Figure 1B).
There was no contact with the vagus nerve. As the
distance between the vagus and the catheter in the
internal jugular vein may vary, the catheter used an
energy of 0.5 to 1 V/kg limited to 70 V, with 30 Hz and
a remarkably short pulse width of 50 ms.
PROCEDURES. Technical details of the several abla-
tion procedures, such as AF ablation, vagal denerva-
tion, accessory pathway ablation, or ventricular
ectopic beats or ventricular tachycardia ablation, will
not be addressed in this study as they are compre-
hensively considered in the bibliographic referencesFIGURE 1 Vagal Stimulation Technique
(A) The neurostimulator used in this research. The electrical features are
the neck showing the close relationship of the jugular vein, carotid arteand are not the aim of the present paper. All cases
were treated with intravenous anesthesia with pro-
pofol under endotracheal intubation and BIS index
control.discussed in the text. (B) Anatomical correlation of the vagus nerve. (C) Transverse section of
ry, and vagus nerve.
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454Bilateral VS were identically performed before and
after ablation in both groups, and the results were
recorded for comparison. All stimulations were car-
ried out with BIS index from 40 to 50 to avoid
signiﬁcant autonomic depression, to have similar
autonomic tone in all evaluations, and to ensure
comfort and safety for patients.
VAGAL STIMULATION. In the supine position, the
irrigated ablation catheter was detached from the RF
generator and was progressed into the internal right
jugular vein up to the level of the upper wisdom tooth
(Figures 1 and 2). The neurostimulator was tempo-
rarily connected between the distal and the third pole
of the RF catheter. From this point, with the catheter
slightly turned to the medial direction, short stimu-
lations and minor adjustments were performed to
search for the position of maximum response on the
basis of the sudden cardioinhibition (sinus arrest or
bradycardia and/or atrioventricular [AV] block)FIGURE 2 Vagal Stimulation Approach
(A) Fluoroscopy of the position of the radiofrequency catheter progress
proximity to the jugular foramen for vagal stimulation (VS). Any new VS
logical position. (B and C) Example of repetitive VS near the right jugular
node arrest. After atropine, the vagal response was completely abolisheinduction (Figure 2B). Afterward, the same type of VS
was performed in the left internal jugular vein. The
best response points were marked with ﬂuoroscopy
where 8 to 12 s of stimulation was performed and
were recorded on each side. Identical VS were made
post-ablation.
Denervat ion group . These patients underwent an
isolated vagal denervation (4) or vagal denervation
with complete AF ablation (9), according to the
methodology previously described and published,
aiming for vagal response elimination or reduction.
The AF ablation was performed with 3 sequential
steps: 1) conventional pulmonary vein isolation; 2) AF
nest ablation; and 3) residual tachycardia (12) ablation
when induced at the end of the procedure. The AF
nests were deﬁned as areas of the atrial wall having
ﬁbrillar myocardium with segmented spectrum in the
frequency domain or fractionated potentials in time
domain by ﬁltering the signal from 300 to 500 Hzed into the right and left internal jugular veins to get appropriate
during the procedure was performed repeating the identical radio-
foramen pre- and post-atropine. The right VS caused immediate sinus
d.
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455(4,9–16). A duodecapolar catheter was placed in the
coronary sinus, and the left atrium was accessed
by transseptal puncture. The 3-dimensional left and
right atrial anatomy was acquired by the Velocity
system in a procedure very similar to a conventional
AF ablation. Intravenous heparin was used to keep
the activated coagulation time from 300 to 400 s.
The ablations were essentially applied to the pul-
monary vein insertion, the AF nests, and over the areas
overlapping the ganglionated cardiac plexuses (GPs):
1. Area of the superior right pulmonary vein GP
through the left atrium (from the insertion of the
right superior pulmonary vein to the interatrial
septum up to the puncture area);
2. Antrum of the pulmonary veins with complete
pulmonary vein isolation in the AF group;
3. Coronary sinus roof through the left atrium aiming
at additional denervation of the inferior vena cava
(IVC) GP;
4. Area of the superior vena cava (SVC) GP (medial
lower part of SVC) reached by the right atrium;
5. Area of the IVC-GP by the right atrium (medial
upper portion of the IVC up to the coronary sinus
ostium); and
6. AF nests located in the left and right surface of the
interatrial septum and in the cristae terminalis.
New VS were performed at the same place as
the pre-ablation ones. In case it was observed at any
degree of vagal response, ablation was revised and
resumed, seeking for AF nests that casually were not
treated in the ﬁrst phase. Again, VS were performed
until complete elimination of the vagal response.
To ﬁnish, having conﬁrmed the absence of vagal
response, these patients underwent an additional
atropine test (infusion of 0.04 mg/kg up to 2 mg)
observing the cardiac rate by 15 min.
Contro l group. These patients underwent a con-
ventional ventricular ablation for treating an acces-
sory pathway or for ablating very frequent ventricular
ectopic beats and/or idiopathic ventricular tachy-
cardia. The transseptal approach was not necessary,
and the ablations were restricted to the ventricular
wall. Three catheters were used: 1 for coronary sinus
mapping, 1 for ventricular pacing, and other for
ablation (irrigated RF catheter, Johnson & Johnson).
Similarly to the DG, before and after ablations, VS was
performed for 10 s with recordings and evaluations of
the responses.
STATISTICAL ANALYSIS. Quantitative data are
shown as the mean  SD. Normality was evaluated by
the Kolmogorov-Smirnov test. Paired or nonpaired
samples 2-tailed Student t tests were applied toestablish comparisons between continuous data
before and after ablation. Statistical analysis was
performed using SPSS Statistics version 19 software
(IBM, Armonk, New York). All 2-tailed p values <0.05
were considered statistically signiﬁcant.
RESULTS
Most cases had easy bilateral access to the internal
jugular vein. VS was easily obtained at several points
from the jugular foramen to the level of the posterior
arch of the third rib; however, stimulations at lower
levels caused signiﬁcant and undesirable stimulation
of the brachial plexus,which can be prevented by using
the upper approach near the jugular foramen. In all but
2 patients, the bilateral VS was obtained. It was
possible to place the catheter and to stimulate each
side very quickly, in 2 to 5 min. All but 1 patient
developed asystole. Only 1 patient developed transi-
tory total AV block. In this case, the response to right VS
was poor, but the left VS produced a consistent tran-
sitory total AV block allowing evaluation of the vagal
denervation. In another case, there was an anatomical
barrier to reach a good left VS. All patients were closely
monitored, and therewas no case of symptoms or signs
related to neurostimulation or vascular injury in a
median follow-up of 8.8  5 months. The ablation
extension was determined by the complete elimina-
tion of the vagal response to VS. The results from the
DG and CG are presented in Table 2.
Both groups presented a massive vagal response
before ablation that completely disappeared in the DG
following ablation (Figures 3 and 4). However, in the
CG, this vagal response persisted practically without
modiﬁcation (pauses comparison pre- and post-
ablation: p ¼ 0.79) (Figures 5 and 6). The pre-
ablation response was not signiﬁcantly different
between groups (p ¼ 0.84). A total of 14 patients in
the DG (29.8%) presented some degree of vagal
response post-ablation that was completely corrected
by resuming the ablation of the targeted areas to
ablate additional AF nests in the same session. In all
patients with cardioinhibitory syncope, the atropine
test was normal pre-ablation (inclusion criterion) and
became negative post-ablation in all cases (the heart
rate changed no more than 1 beat/min).
In patients with Wolff-Parkinson-White syndrome,
atrial pacing was performed during VS post-ablation
to prove the accessory pathway elimination. The
result was the same as obtained with the adenosine
test: the pre-excitation was eliminated in all patients
but 1, who was successfully treated in the same
session with additional ablation. There were no
complications.
TABLE 2 Results Pre- and Post-Ablation
Group Patients Age (yrs) Diagnostic
Vagal Response
Pre (n)
Pause
Pre Procedure
Vagal Response
Post
Pause
Post Drug Test
Denervation group
VVS 7
(5 M)
35.7  13.0 SCIS Asy or AVB 12.4  2.2 CNA None 0 Atropine no response
VRAF 40
(32 M)
52.9  14.2 VRAF Asy or AVB/AF (10)* 11.3  1.8 AF Abl þ CNA None/No AF 0 —
Control group
AP 13
(10 M)
32.0  14.0 7 WPW
6 CAP
Asy or AVB/AF (2)* 11.5  2.3 AP Abl Asy or AVB 11.3  2.1 Adenosine TCAB
VA 4
(1 M)
47.5  13.4 VEB/NSVT/IVT Asy or AVB/VEB/NSVT (3)† 11.3  2.0 Abl VEB/VT Asy or AVB 11.3  2.1 —
*10 patients in the VRAF group and 2 in the AP group presented with spontaneous AF after asystole. †In the VA group, 2 patients presented with VEB and 1 presented with NSVT following the VS. Comparison
of pre-ablation pauses of denervation group vs. control group: p ¼ 0.79; comparison of pauses pre- and post-ablation in control group: p ¼ 0.84.
Abl ¼ ablation; AF ¼ atrial ﬁbrillation; AP ¼ accessory pathway; Asy ¼ asystole; AVB ¼ atrioventricular block; CAP ¼ concealed accessory pathway; CNA ¼ cardioneuroablation; IVT ¼ idiopathic ventricular
tachycardia; M ¼ male; NSVT ¼ nonsustained ventricular tachycardia; SCIS ¼ severe cardioinhibitory syncope; TCAB ¼ transitory complete atrioventricular block; VA ¼ ventricular arrhythmia; VRAF ¼ vagal
related atrial ﬁbrillation; VVS ¼ vasovagal syncope; WPW ¼ Wolff-Parkinson-White; — ¼ not necessary; other abbreviations as in Table 1.
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456DISCUSSION
A simple method of VS during electrophysiological
procedures is very timely and appropriate due to the
worldwide increase in autonomic cardiac inter-
ventions (10,11,17,18). In the ﬁrst cardioneuroablation
study (4), intravenous atropine was employed to
determine whether the vagal denervation was com-
plete. Additional ablation had to be performed in case
of response. However, the long autonomic atropine
effect (average half-life of 4.1 h) made any further
evaluation difﬁcult. For this reason, a simpliﬁed VS
that can be repeated at any time during stepwise ab-
lations causing no persistent autonomic modiﬁcation
seems to be attractive.
Because of the steerability for vein catheterization,
the RF catheter was elected for VS by detaching itFIGURE 3 An Example of a Patient From the Denervation Group Pre
The upper strip shows 9.8 s of vagal stimulation (VS) causing a pause (as
is repeated in the same place causing no pause (lower strip), demonstr
remains normal without any change in the heart rate and in the atrioven
cases is considered the primary endpoint for this procedure. RA ¼ rightfrom the RF generator, although any other electro-
physiology catheter could also be used for this pur-
pose depending on the convenience of the operator.
As the sympathetic ﬁbers usually regenerate in a
few months, the term “parasympathetic denervation”
could be correct only for the late phase. In the acute
phase, there are both a parasympathetic and a sym-
pathetic denervation (autonomic denervation); how-
ever, by using the VS in this study, we were able to
test only the vagal (parasympathetic) denervation.
The sympathetic one was not accessed.
The feasibility and the immediate effect of this
stimulation could be quickly observed before and after
the electrophysiological procedures. Nevertheless, it
is essential to assess whether the electrophysiological
manipulation would cause some residual undesirable
inﬂuence on the VS response. Therefore, our studysenting With Severe Cardioinhibitory Syncope
ystole) of 12.8 s pre-ablation. Following the vagal denervation, the VS
ating a clear vagal denervation. During the stimulation, the rhythm
tricular conduction. The complete absence of vagal response in these
atrial channel.
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457included a DG on the basis of CNA, whose primary
objective was vagal denervation, and a CG in which
extensive electrophysiological manipulation would be
performed, but without aiming at vagal denervation.
The results showed that VS was easily obtained, was
repeated during and at the end of the procedures, and
was quite useful for evaluating electrophysiological
parameters. The stimulation was reliable as it was
not changed by anesthesia and electrophysiology
handling, showing speciﬁcity for vagal denervation. In
addition, VS was found to be harmless, having no re-
sidual effect during a mean follow-up of 8.8  5.0
months, and it was also an inexpensive alternative
with a high potential for employment in diagnostic,
therapeutic, and investigational electrophysiology.
VS is also a fundamental resource in the possibility
of attaining a signiﬁcant, persistent, or permanent
vagal denervation through catheter ablation. This may
be of interest as it can potentially allow for treatment of
functional bradyarrhythmias without pacemaker im-
plantation (10). The long-term outcomes of this ther-
apy are showing remarkable results, reinforcing its
potential therapeutic value (11). Nevertheless, its suc-
cess depends on the correct demarcation of the sites
that allow for extensive and long-lasting para-
sympathetic denervation. In this sense, it is essential
to eliminate the cell body of the post-ganglionic para-
sympathetic neuron, widely spread in the atrial walls
(AF nests) and cardiac GP (19,20). Indeed, the atrial
conventional ablation, mainly the AF ablation, elimi-
nates cell bodies of parasympathetic postganglionic
efferent neurons and the neuronal ﬁbers of theFIGURE 4 An Example of a Patient in the Denervation Group Presen
The upper strip shows a VS during 9 s that causes an immediate pause,
induction of atrial ﬁbrillation (AF). The RA shows the sinus rhythm on t
patient was treated with conventional AF ablation plus vagal denervatio
procedures, the VS was repeated for 11.5 s, and no pause and no AF we
reaching an important immediate endpoint of the treatment. Abbreviatisympathetic efferent and sensory afferent. Several
studies have shown that the ﬁbers regenerate if the cell
body is preserved (21,22). Thus, although there is
sympathetic and sensory reinnervation, an extensive
and permanent parasympathetic denervation can be
observed due to elimination of the parasympathetic
postganglionic cell body neurons located in the atrial
walls (AF nests) and even in the GP. That is the main
purpose of this technique. However, the success de-
pends on absolute conﬁrmation of wide vagal dener-
vation that can be progressively tested during the
ablation by themethod proposed here (Figures 3 and 4).
Another potential convenience of direct vagal
denervation is in the treatment of the VRAF (1,2,4). In
these cases, validation of the vagal denervation
during ablation seems to be a signiﬁcant hint. Addi-
tionally, in this group, the spontaneous appearance of
AF following the asystole caused by the VS is very
interesting, linking the AF trigger to the vagal tone
modiﬁcation (Figure 4). Also, we have observed that
the appearance of AF can be greatly increased by VS
during isoproterenol infusion. However, that was not
the aim of the current study.
Besides the spontaneous induction of AF, another
potential usage of VS was to detect the presence of a
second accessory pathway during Wolff-Parkinson-
White syndrome ablation (mainly useful in cases
with contraindication to adenosine) (Figure 6). Both,
right and left VS cause immediate sinus depression;
however, for accessory pathway searching, the left VS
is likely more appropriate as it usually causes func-
tional AV block due to AV nodal inhibition. In thisting With AF Typically Related to Increase of the Vagal Tone
leading to an asystole of 10.2 s that was followed by a spontaneous
he left, the sinus pause in the middle, and the AF on the right. This
n to abolish the vagal induction of the arrhythmia. At the end of the
re observed. There was a complete absence of the vagal response,
ons as in Figure 3.
FIGURE 5 An Example of the Control Group
This patient had very symptomatic ventricular ectopic beats that were successfully treated by RF ablation in the right ventricle. Before ablation,
8 s of VS caused a pause of 13.4 s. Following the ablation, a new VS of 8 s produced another pause of 15.3 s. This assay shows the reproducibility
of this VS method and also shows that there is no change in vagal function in cases without autonomic ablation. Abbreviations as in Figure 3.
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458sense, the endovascular stimulation of the left pul-
monary artery is another source of AV block induction
with less effect over the sinus node.
In addition, VS may be helpful for supraventricular
tachycardia reversion, VRAF reproduction, and even
restarting missed ventricular ectopic beats, helping
the pace-mapping and testing the ablation result.
All of these potential beneﬁts justify an easy,
low-cost, reliable, and transient VS, particularly if its
effect vanishes in a few seconds, as does the VS pro-
posed in this study.
Although not the aim of the present paper, as the
vagal denervation is the “study model” in this
research, it is timely to comment about the mapping
of vagal innervation. Beyond the pulmonary veinFIGURE 6 Patient From the Control Group With Ablation Not Aimin
This patient was included to test the vagal stimulation (VS) pre- and post
had no intention of autonomic denervation. In the upper strip, VS was app
(A), followed by a short period of atrial pacing (black arrows) during V
conduction over the accessory pathway, as it is not depressed by the vag
syndrome) became aberrant, revealing the presence of the anomalous co
and subsequently the accessory pathway elimination. There is a long asy
without denervation preserves the vagal function. In D, there was a shor
complete atrioventricular block, caused by the vagal action and absence
atrioventricular block (E) induced by adenosine, proving the lack of abn
The latter can be useful in cases with adenosine contraindication. P ¼ bantrum, the targets for ablation were deﬁned by map-
ping the neuro–myocardial interface and anatomically
overlapped regions of cardiac GP. The former was
carried out on the basis of the identiﬁcation of AF nests
(12–15) according to themethodology of the CNA (4,11).
As conﬁrmed by other studies, the AF nests are present
even in the absence of AF and represent areas of higher
innervation density related to the neuro–myocardial
interface (16). Thus, their elimination results in vagal
denervation, previously shown in the initial study by
the abolishment of the atropine response. Mapping
was complemented with RF application in anatomic
regions related to the main cardiac GP. Beyond the AF
nest mapping, functional studies have conﬁrmed that
there are 3 main parasympathetic GP located ing for Vagal Denervation
- Wolff-Parkinson-White syndrome ablation. In this case, the ablation
lied during 10 s. Just at the beginning, there is immediate sinus pause
S (B). At this moment, despite the nodal block, the patient presents
al action. The previous short QRS (unapparent Wolff-Parkinson-White
nduction. Themiddle strip shows a new VS, at the end of the ablation,
stole (12.8 s) beginning in C, showing that the conventional ablation
t period of atrial pacing (black arrows) showing functional transitory
of the abnormal conduction. In the lower strip is shown a short
ormal conduction. This effect is similar to the atrial pacing during VS.
locked P-wave due to the vagal effect.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The possibility
of having a simpliﬁed technique to check the vagal action
repeatedly without residual effects during electrophysiology
studies is very attractive. After the publication of the long-term
cardioneuroablation results, there has been growing interest in
vagal denervation techniques that has led to the development of
randomized trials to test this new therapeutic approach. A major
application is the treatment of the cardioinhibitory vasovagal
syncope by ablation without pacemaker implantation. However,
the future of this therapy relies on an accurate validation of
denervation during and immediately at the end of the procedure.
In this setting, VS is essential to rationalize, validate, and opti-
mize the results of this new therapeutic option and could
constitute an indispensable tool in this type of study.
TRANSLATIONAL OUTLOOK: VS is also critical to conﬁrm the
denervation in other applications, such as in cardioneuroablation
for the treatment of sinus node dysfunction, functional brady-
tachy syndrome, functional AV block, and vagal atrial ﬁbrillation.
By mimicking a kind of electronic adenosine, the VS may have
several potential diagnostic applications in electrophysiology
studies, such as identiﬁcation of unapparent anterograde or
retrograde accessory pathways (by AV nodal block induction),
reversion of cholinergic-dependent tachycardias, reproduction of
vagal AF, and assessment of the vagal depression degree of the
sinus node and the AV conduction in autonomic studies. Last, this
kind of VS may have potential additional uses for studying
efferent and afferent vagal effects by evoked responses in the
heart and in the central nervous system, respectively.
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459epicardial fat pads (23). Most of the vagal innervation
of the sinus node originates from the SVC-GP and su-
perior right pulmonary vein GP, whereas most vagal
innervation of the AV node originates from the IVC-GP.
Thus, it is possible to get a wide vagal denervation by
anatomically ablating the atrial endocardium over-
lapping the GP areas (23).
STUDY LIMITATIONS. In this study, we used the most
intense vagal response, regardless of the side; how-
ever, more detailed researches of vagal response from
each side will be highly desirable. Nonsimultaneous
bilateral VS was the rule in CNA; however, it was not
performed in all cases of VRAF and in the patient with
anatomical barrier.
Another important issue would be the study of the
laterality of the VS that was not foreseen in this initial
paper; nevertheless, by using the present stimulation
parameters, the VS caused a massive depression of
both the sinus node (asystole) and of the AV node
(complete AV block), independent of the stimulated
side. This suggests that there is probably a great blend
of ﬁbers from both vagus nerves innervating most of
the GPs at the end. The absolute requirement of bilat-
eral VS cannot be elucidated with the present study.
Because both sinus and AV node denervation are
equally desired, a solution could be to stimulate one
side 2 times: ﬁrst without and second with atrial pac-
ing. If both asystole and total AV block are demon-
strated, the contralateral vagal stimulation would not
be necessary. This protocol was not used in this initial
investigation, as the focus was only the VS feasibility.
This study did not include the long-term follow-up
of denervation, accessory pathways, or ventricular
arrhythmia ablation because the aim was to show the
immediate vagal effect under VS, its complete
disappearance after acute vagal denervation, and its
maintenance without change on ablations without
denervation.
CONCLUSIONS
The VS method proposed in the current study was
feasible, easy, reversible in a few seconds, harmless,
reliable, inexpensive, and showed no complications.
It seems to be a potential tool for the immediate
conﬁrmation of vagal denervation, for evaluating the
progression of the parasympathetic denervationduring ablation, and for autonomic tests during any
electrophysiological study. The vagal denervation
methodology used in this controlled investigation
showed complete elimination of the vagal response.
Ablation without denervation did not affect the vagal
response, indicating that this parameter is consistent
and does not change with general anesthesia and
electrophysiological handling.
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